Stay updated on REGN4336 in Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the REGN4336 in Prostate Cancer Clinical Trial page.

Latest updates to the REGN4336 in Prostate Cancer Clinical Trial page
- Check5 days agoChange DetectedRevision history now includes v3.6.2 and no longer lists v3.6.0. This change reflects an update to the page's version history rather than modifications to the study content.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedQuick-access links for 'Check who can join' and 'Find Contact Information' have been added to the study history page, improving user ability to assess eligibility and reach the study team. The revision history now shows the latest release as v3.6.0, replacing the previous v3.5.5.SummaryDifference0.4%

- Check27 days agoChange DetectedA new revision tag, v3.5.5, is added to the history and the previous v3.5.4 tag is removed. This updates the page's revision history.SummaryDifference0.1%

- Check48 days agoChange DetectedA new revision entry v3.5.4 was added to the history while the previous revision v3.5.3 was removed, indicating an update to the page itself rather than changes to the trial data.SummaryDifference0.1%

- Check55 days agoChange DetectedThe study title was updated to state REGN4336 is safe and works alone and in combination with REGN5678, removing Cemiplimab from the combination; the record history also adds several sections (IPDSharing, Eligibility, Outcome Measures, Arms and Interventions, Study Design, Conditions, Study Description, Study Status, and Study Identification) to provide a more complete data representation.SummaryDifference1%

- Check69 days agoChange DetectedThis update reflects a revision/version bump on the ClinicalTrials.gov page interface (from v3.5.2 to v3.5.3), without indicating any changes to the study record details shown in the record history.SummaryDifference0.1%

Stay in the know with updates to REGN4336 in Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the REGN4336 in Prostate Cancer Clinical Trial page.